Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 25, 2009
Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity
Raj Padwal
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 9, 2008
Cetilistat, a new lipase inhibitor for the treatment of obesity
Raj Padwal
Diabetes Care
|
December 25, 2003
Antihypertensive therapy and incidence of type 2 diabetes: a systematic review
Raj Padwal, Andreas Laupacis
Annals of Internal Medicine
|
October 6, 2025
In T2D and hypertension, the lower-sodium DASH4D diet reduced SBP more than a higher-sodium comparison diet at 5 wk
Darren Lau, Raj Padwal,
Annals of Internal Medicine
|
August 2, 2021
In adults with overweight or obesity, continued weekly semaglutide after a 20-wk run-in improved weight loss
Darren Lau, Raj Padwal
Current Hypertension Reports
|
September 15, 2005
Antihypertensive drugs and incidence of type 2 diabetes: evidence and implications for clinical practice
Samuel Asfaha, Raj Padwal
Annals of Internal Medicine
|
October 6, 2025
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk
Arnav Agarwal, Raj Padwal,
Journal of Human Hypertension
|
October 11, 2022
Automated blood pressure measuring devices: how are they clinically validated for accuracy?
Jennifer S Ringrose, Raj Padwal
The Canadian Journal of Cardiology
|
December 19, 2020
Digital Health Approaches for the Assessment and Optimisation of Hypertension Care Provision
Raj Padwal, Peter W Wood
Journal of Hypertension
|
July 30, 2021
Knowledge, perception and practice of Québec nurses for ambulatory and clinic blood pressure measurement methods: are we there yet?
Shweta Todkar, Raj Padwal, Lyne Cloutier
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 25, 2009
Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity
Raj Padwal
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 9, 2008
Cetilistat, a new lipase inhibitor for the treatment of obesity
Raj Padwal
Diabetes Care
|
December 25, 2003
Antihypertensive therapy and incidence of type 2 diabetes: a systematic review
Raj Padwal, Andreas Laupacis
Annals of Internal Medicine
|
October 6, 2025
In T2D and hypertension, the lower-sodium DASH4D diet reduced SBP more than a higher-sodium comparison diet at 5 wk
Darren Lau, Raj Padwal,
Annals of Internal Medicine
|
August 2, 2021
In adults with overweight or obesity, continued weekly semaglutide after a 20-wk run-in improved weight loss
Darren Lau, Raj Padwal
Current Hypertension Reports
|
September 15, 2005
Antihypertensive drugs and incidence of type 2 diabetes: evidence and implications for clinical practice
Samuel Asfaha, Raj Padwal
Annals of Internal Medicine
|
October 6, 2025
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk
Arnav Agarwal, Raj Padwal,
Journal of Human Hypertension
|
October 11, 2022
Automated blood pressure measuring devices: how are they clinically validated for accuracy?
Jennifer S Ringrose, Raj Padwal
The Canadian Journal of Cardiology
|
December 19, 2020
Digital Health Approaches for the Assessment and Optimisation of Hypertension Care Provision
Raj Padwal, Peter W Wood
Journal of Hypertension
|
July 30, 2021
Knowledge, perception and practice of Québec nurses for ambulatory and clinic blood pressure measurement methods: are we there yet?
Shweta Todkar, Raj Padwal, Lyne Cloutier
Page
of 11